124 related articles for article (PubMed ID: 31722837)
1. [Diagnostic performance of κ/λ serum free light chain ratio (Freelite® assay) and IgGκ/IgGλ ratio (Hevylite® assay) as prognostic biomarkers of the evolution of immune thrombocytopenia into a chronic disease in adult patients].
Martellosio JP; Barra A; Roy-Peaud F; Souchaud-Debouverie O; Martin M; Lateur C; Gombert JM; Roblot P; Puyade M
Rev Med Interne; 2020 Jan; 41(1):3-7. PubMed ID: 31722837
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
[TBL] [Abstract][Full Text] [Related]
3. Heavy/light chain assay in the monitoring of multiple myeloma.
Ting HY; Sthaneshwar P; Bee PC; Shanmugam H; Lim M
Pathology; 2019 Aug; 51(5):507-511. PubMed ID: 31253381
[TBL] [Abstract][Full Text] [Related]
4. Biological variation of immunoglobulin heavy chain-light chain pairs in serum.
Finlay JA; Wu AH
Clin Chim Acta; 2014 Sep; 436():68-71. PubMed ID: 24824555
[TBL] [Abstract][Full Text] [Related]
5. Detection of oligoclonal IgG kappa and IgG lambda bands in cerebrospinal fluid and serum with Hevylite™ antibodies. comparison with the free light chain oligoclonal pattern.
Zeman D; Hradílek P; Svagera Z; Mojžíšková E; Woznicová I; Zapletalová O
Fluids Barriers CNS; 2012 Feb; 9(1):5. PubMed ID: 22360869
[TBL] [Abstract][Full Text] [Related]
6. Analysis of patients with γ-heavy chain disease by the heavy/light chain and free light chain assays.
Kaleta E; Kyle R; Clark R; Katzmann J
Clin Chem Lab Med; 2014 May; 52(5):665-9. PubMed ID: 24327529
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Free Light Chain Assays: Freelite and N Latex in Diagnosis, Monitoring, and Predicting Survival in Light Chain Amyloidosis.
Mahmood S; Wassef NL; Salter SJ; Sachchithanantham S; Lane T; Foard D; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
Am J Clin Pathol; 2016 Jul; 146(1):78-85. PubMed ID: 27353767
[TBL] [Abstract][Full Text] [Related]
8. Correlations among different markers determined by immunochemical methods used for the diagnosis and monitoring of intact immunoglobulin multiple myeloma cases.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2012; 71(4):183-200. PubMed ID: 23755700
[TBL] [Abstract][Full Text] [Related]
9. A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain.
Tadmor T; Braester A; Najib D; Aviv A; Herishanu Y; Yuklea M; Shvidel L; Rahimi-Levene N; Ruchlemer R; Arad A; Fogl C; Henig C; Barak M; Magal L; Polliack A; Townsend K;
Eur J Haematol; 2019 Oct; 103(4):335-341. PubMed ID: 31278876
[TBL] [Abstract][Full Text] [Related]
10. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
Scudla V; Lochman P; Pika T; Minarik J; Zapletalova J; Bacovsky J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of Relationship between Serum Total Light Chain κ/λ Ratio and Proportion of Bone Marrow Plasma Cells in Patients with IgG type and IgA type Multiple Myeloma].
Zhu AY; Zhu FB; Wang FC; Zhang LJ; Ma Y; Hu JG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1454-1459. PubMed ID: 29070124
[TBL] [Abstract][Full Text] [Related]
12. Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.
Beaumont-Epinette MP; Moreau C; Besnard S; Latute F; Collet N; Sebillot M; Grosbois B; Bendavid C; Guenet L; Decaux O
Pathol Biol (Paris); 2015 Sep; 63(4-5):215-21. PubMed ID: 26319969
[TBL] [Abstract][Full Text] [Related]
13. [Free light chains assay: Indications and methods].
Martellosio JP; Leleu X; Roblot P; Martin M; Puyade M
Rev Med Interne; 2019 May; 40(5):297-305. PubMed ID: 30862366
[TBL] [Abstract][Full Text] [Related]
14. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X
Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271
[TBL] [Abstract][Full Text] [Related]
15. The association of serum-free light-chain levels with markers of renal function.
Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H
Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734
[TBL] [Abstract][Full Text] [Related]
16. Serum Hevylite
Yogev D; Pick M; Slyusarevsky E; Pogrebijski G; Pickin A; Gatt ME
Int J Lab Hematol; 2021 Jun; 43(3):418-425. PubMed ID: 33455086
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Freelite and N-Latex serum free light chain assays: a critical review.
Daves M; Piccin A; Roccaforte V; Lippi G
Biochem Med (Zagreb); 2021 Oct; 31(3):030701. PubMed ID: 34393594
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio.
Prokaeva T; Spencer B; Sun F; O'Hara RM; Seldin DC; Connors LH; Sanchorawala V
Amyloid; 2016 Dec; 23(4):214-220. PubMed ID: 27677679
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients.
Ludwig H; Milosavljevic D; Zojer N; Faint JM; Bradwell AR; Hübl W; Harding SJ
Leukemia; 2013 Jan; 27(1):213-9. PubMed ID: 22955329
[TBL] [Abstract][Full Text] [Related]
20. Prognostic utility of intact immunoglobulin Ig'κ/Ig'λ ratios in multiple myeloma patients.
Bradwell A; Harding S; Fourrier N; Mathiot C; Attal M; Moreau P; Harousseau JL; Avet-Loiseau H
Leukemia; 2013 Jan; 27(1):202-7. PubMed ID: 22699454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]